Provider review
HelloWellness review
Every product struck through, at discounts from a third to four fifths.
The underlying prices are low for this category — and no figure carries a billing period.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
HelloWellness
$133 sema · $166 tirz, no billing period stated
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The catalog here is priced entirely in discounts, and the discounts are the problem rather than the prices. Every product on the page is shown at a reduced figure against a higher struck-through one, which on its own is unremarkable — most of this category does it. What is unusual is the spread. The reduction runs from roughly a third on one product to more than four fifths on another, and there is no evident logic connecting them: a percentage that varies that much across a single catalog is not describing what those items used to cost, it is setting an anchor per item. Read that way, the higher numbers carry no information and the lower ones are simply the prices. Those prices are competitive — the compounded semaglutide figure in particular sits at the lower end of what this site has recorded — so the underlying offer may well be good. The gap is the same one that keeps recurring and it matters more here because the figures are attractive: no billing period is attached to anything, so you cannot tell whether these are monthly rates, one-time vial prices, or a supply of some other length, and cannot therefore compare them against anything. Both molecules are named, which helps, and no dose is published, which does not.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want both molecules named and priced at figures low for this category
- You want a wider catalog of injectables available under one account
- You are willing to confirm the billing period directly before ordering
Look elsewhere if
- You are comparing monthly rates. No figure here carries a period
- You are measuring the advertised saving. Every product is permanently discounted
- You want a dose behind the number. None is published
What it actually costs
Price as published
No billing period is stated against any figure. Compounded semaglutide is shown at $133 struck through from $198, and tirzepatide at $166 struck through from $247, with the same treatment across the rest of the catalog — NAD+ at $79 from $117, MICC at $199 from $386 and sermorelin at $116 from $599 · every single product carries a struck-through comparison price, and the size of the reduction swings wildly: about a third off the NAD+ line and more than four fifths off the sermorelin one · a discount applied permanently to everything is a price rather than a saving, and a range that wide suggests the struck figures are set per product rather than reflecting any former rate · the current and struck figures were separated by reading the price elements themselves, not their order — the struck one computes to a line-through and the current one does not · both molecules are named · no dose is published
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. No billing period is attached to any figure, so nothing here can be compared against the monthly rates that make up most of this market — a real problem because the underlying prices are low for this category. Every product is permanently struck through and the reduction swings from about a third to more than four fifths across one catalog, which is not describing what those items used to cost but setting an anchor per item. The current and struck figures were separated by reading the price ELEMENTS rather than their order. Both molecules are named. No dose published and no low-dose product offered.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Both molecules are named and priced separately, at figures low for this category.
- A wider catalog of injectables is priced on the same page under one account.
- The current price is displayed prominently rather than hidden behind the struck one.
Pharmacy, labs and oversight
HelloWellness does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What HelloWellness publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The catalog here is priced entirely in discounts, and the discounts are the problem rather than the prices. Every product on the page is shown at a reduced figure against a higher struck-through one, which on its own is unremarkable — most of this category does it. What is unusual is the spread. The reduction runs from roughly a third on one product to more than four fifths on another, and there is no evident logic connecting them: a percentage that varies that much across a single catalog is not describing what those items used to cost, it is setting an anchor per item. Read that way, the higher numbers carry no information and the lower ones are simply the prices. Those prices are competitive — the compounded semaglutide figure in particular sits at the lower end of what this site has recorded — so the underlying offer may well be good. The gap is the same one that keeps recurring and it matters more here because the figures are attractive: no billing period is attached to anything, so a reader cannot tell whether these are monthly rates, one-time vial prices, or a supply of some other length, and cannot therefore compare them against anything. Both molecules are named, which helps, and no dose is published, which does not.
The honest cons
No billing period is attached to any figure, so none can be compared.
- Every product is permanently struck through, at wildly inconsistent ratios.
- No dose is published behind either molecule's price.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
HelloWellness is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#273 of 373
Ordered with the companies that pay us first, and HelloWellness is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.